Faustin Benjamin, Reed John C
Sandford-Burnham Institute for Medical Research, La Jolla, CA, USA.
Methods Mol Biol. 2013;1040:137-52. doi: 10.1007/978-1-62703-523-1_11.
Nucleotide-binding domain leucine-rich-repeat containing receptors; NOD-Like Receptors (NLRs) were originally described as microbial sensors involved in host defense against pathogens that comprise an important component of the innate immune system. Recently, their cellular functions have expanded beyond classical pathogen detection, to danger sensors that may contribute to the pathophysiology of a wide range of inflammation-driven human illnesses such as metabolic diseases (atherosclerosis, obesity, type 2 diabetes, gout, age-related macular degeneration) and neurological disorders (Alzheimer's disease). Pathogen-stimulated NLRs such as NLR family Pyrin domain-containing protein 1 (NLRP1) assemble into molecular platforms called "inflammasomes" to activate inflammatory protease caspase-1, which processes pro-IL-1β and pro-IL-18 into active cytokines. We describe methods for reconstituting the human NLRP1 inflammasome in vitro. Protocols are provided for: (a) expression and purification of inflammasome core components (NLRP1 and pro-caspase-1 proteins) using the baculovirus/insect cell expression system, and (b) functional monitoring of NLRP1-mediated caspase-1 activation in response to NLRP1 ligand muramyl dipeptide (MDP) and ATP.
含核苷酸结合结构域富含亮氨酸重复序列的受体;NOD样受体(NLRs)最初被描述为参与宿主抵御病原体的微生物传感器,是先天免疫系统的重要组成部分。最近,它们的细胞功能已从经典的病原体检测扩展到危险传感器,可能导致多种炎症驱动的人类疾病的病理生理学变化,如代谢性疾病(动脉粥样硬化、肥胖症、2型糖尿病、痛风、年龄相关性黄斑变性)和神经疾病(阿尔茨海默病)。病原体刺激的NLRs,如NLR家族含吡啉结构域蛋白1(NLRP1),组装成称为“炎性小体”的分子平台,以激活炎性蛋白酶半胱天冬酶-1,该酶将前白细胞介素-1β和前白细胞介素-18加工成活性细胞因子。我们描述了在体外重建人NLRP1炎性小体的方法。提供了以下方案:(a)使用杆状病毒/昆虫细胞表达系统表达和纯化炎性小体核心成分(NLRP1和前半胱天冬酶-1蛋白),以及(b)监测NLRP1介导的半胱天冬酶-1对NLRP1配体胞壁酰二肽(MDP)和ATP的激活功能。